Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Takeuchi

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Annals of General Psychiatry|September 28, 2020
A cross-sectional study on metabolic similarities and differences between inpatients with schizophrenia and those with mood disordersYoriyasu Uju, Tetsuto Kanzaki, Yuki Yamasaki, et al.
Annals of Neurology|March 5, 2009
Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophyHaruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, et al.
The Lancet. Neurology|August 10, 2010
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trialMasahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Annals of General Psychiatry|September 28, 2020
A cross-sectional study on metabolic similarities and differences between inpatients with schizophrenia and those with mood disordersYoriyasu Uju, Tetsuto Kanzaki, Yuki Yamasaki, et al.
Annals of Neurology|March 5, 2009
Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophyHaruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, et al.
The Lancet. Neurology|August 10, 2010
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trialMasahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, et al.
Pageof 4